Germany’s state economic development bank, the KfW, says that financing of start-ups increased by six percent annually in the first quarter of this year.
BERLIN, May 5, 2026 — 1.7 billion euros flowed into young companies in Europe’s largest economy, according to a new KfW study. The rise is down to a broad development on the VC market rather than a handful of mega-deals, the bank added.
International investors are playing a major role in this trend. 34 percent of the capital given to German companies came from the United States.
“The robust international presence reflects both the fundamentally high level of activity of US investors and the abiding confidence of international providers of capital in Germany as a location for starting technology companies,” said KfW head economist Dirk Schumacher in a statement.
18 percent of German-based start-ups receiving capital in the first three months of 2026 come from the health sector, followed by fintechs with 15 percent. Companies developing artificial intelligence applications accounted for over half – 967 million euros – of investments.
“The increasing capital flowing to German start-ups shows that the activities of young non-LLM artificial intelligence companies are eliciting significant interest from foreign investors,” says Germany Trade & Invest AI expert Asha-Maria Sharma. “The proximity to renowned universities and research institutions and the focus on technology-driven business models make fledgling companies in Germany attractive to VC investors.”
Germany Trade & Invest is the German government agency for international business promotion and is owned by the Ministry for Economic Affairs and Energy. It helps international companies do business in Germany and German companies do business abroad.
Leumi Partners has joined the fund as an anchor investor
The fund has already invested in five companies, including ones founded by serial entrepreneurs and alongside some of the world’s leading venture capital firms
TEL AVIV, Israel, May 5, 2026 — After leading dozens of investments, primarily in the cybersecurity space that have so far generated 22 exits with a combined value of approximately $2.5 billion, Yaron Elad and Elik Etzion are embarking on a new path. Together with their US-based partner Gurinder Sidhu, they are launching AlphaDrive, a $100 million fund focusing on cybersecurity and AI, operating under a unique investment model.
Leumi Partners, the investments arm of Bank Leumi, has joined the fund as an anchor investor, alongside additional investors including “Aurum” the Kahn family office, cybersecurity entrepreneurs from Israel and the U.S., venture capital fund managers, and other investors from the U.S. and Europe.
Yaron Elad, a seasoned venture capital investor and former CEO of Elron Ventures, and Elik Etzion, a cybersecurity and AI expert and former deputy head of the cyber division of Unit 8200 and former CISO of Bank Hapoalim, stepped down from the management of Elron Ventures in 2025, after leading it to top-decile performance in Cyber investments.
Gurinder Sidhu is a seasoned investment banker who until recently led the cybersecurity and infrastructure software sector at UBS, the world’s largest wealth management bank. In his role, Sidhu led M&A and financing transactions for leading cybersecurity companies including CrowdStrike, CyberArk, SentinelOne, Barracuda, Sophos and Varonis.
AlphaDrive plans to invest in companies across various stages, from seed to later stages, alongside larger-scale co-investments with Leumi Partners. The fund is expected to invest in companies founded by Israeli entrepreneurs. To date, it has invested in five startups, including companies founded by serial entrepreneurs operating at the intersection of AI and cybersecurity, alongside leading funds such as Greylock, Accel, CRV, Notable, Viola Ventures, and others.
AlphaDrive focuses on the intersection of the AI revolution and the cybersecurity world, a convergence that is driving profound change in the industry. At a time when AI giants are developing and releasing dedicated models used by both attackers and defenders, the industry is being fundamentally reshaped as these models absorb the logic of existing cybersecurity products. This trend is already reflected in the pricing volatility of publicly traded cybersecurity companies.
Alongside these challenges, significant opportunities are emerging for startups to challenge established cybersecurity companies through AI-native products that integrate multiple models, automate workflows via AI agents that replace human labor, and introduce new business models.
The AI revolution is also reshaping the venture capital industry itself, the boundaries between product and service companies are blurring, distinctions between early and late-stage companies are fading, development cycles are shortening, and AI-native companies can achieve meaningful revenues in a short time. Even internal fund operations are adapting to the AI era.
Against this backdrop, AlphaDrive has developed a unique investment model that combines several complementary and dynamic strategies. Integrating venture capital and private equity methodologies for AI-driven roll-up strategies (technology-enabled serial M&A), investing across the full company lifecycle, and building companies with serial entrepreneurs under a Foundry model. This model is supported by a global, multidisciplinary team with extensive shared experience.
The fund’s team also includes Sharon Wagner, a serial entrepreneur who has sold several companies to technology giants including Microsoft; Dr. Uri Geiger, a venture capital and private equity investor; Kobi Katz, CTO of Maccabi Healthcare Services; and Susanne Senoff, who serves as CISO at Thoma Bravo Group company. In addition, senior technology and cybersecurity executives from international companies. Including TikTok, Warner, Chime, and Medtronic, are part of the extended team.
Yaron Elad, Managing Partner at AlphaDrive, said: “We built AlphaDrive after decades of working closely with entrepreneurs across the entire lifecycle of companies, from the earliest stages, through growth, to exit. Building a company has always been a roller coaster, but in the AI era it has become faster, sharper, and far more unpredictable.
“We see our role as partners in this journey, with a deep understanding of what it takes to build companies that succeed over time. AlphaDrive was established to operate precisely at these inflection points, with expertise in cybersecurity and AI, and with the ability to work with companies at different stages helping them grow effectively in the new world being built before our eyes.”
Elik Etzion added: “We are in the midst of a powerful convergence between two of the world’s fastest-growing industries, AI and cybersecurity, and this convergence is reshaping the rules of the game. At AlphaDrive, we are here to seize the moment. We have built a dedicated Cyber-AI task force, a unique team with proven experience navigating previous waves of transformation and disruption in the industry. Our goal is to enable entrepreneurs to seize the current window of opportunity and provide them with a broad value platform that will allow them to build companies shaping the future of the industry.”
Doubles down on building the First Agentic Operating System for eCommerce scale
TEL AVIV, Israel, May 5, 2026 — ZyG today announced that it has raised a $60M Series A round led by Accel, with participation from Felix Capital and additional new and existing investors, including Bessemer Venture Partners and Lightspeed Venture Partners. Sonali De Rycker, partner at Accel, will be joining the ZyG board of directors.
ZyG was built by the founders of ironSource, which went public on the NYSE at $11B and later merged with Unity, who joined forces with three of the leading AI experts from one of Israel’s top cyber units. The founders bring a deep combination of business, tech and eCom expertise to one of the largest problems in eCommerce.
ZyG OS is the first end-to-end platform for entrepreneurs and direct-to-consumer (DTC) brands to build eCommerce scale. Leveraging its agentic infrastructure, ZyG OS identifies products with strong scale potential and executes every function needed for scale, from building the online brand and store to generating creatives, running user acquisition and organic growth to optimizing conversion, retention, and logistics. By removing operational and data complexity, as well as the financial risk inherent in scaling, ZyG enables product innovators to focus on building great products.
ZyG is currently partnering with online brands with excellent products that have gotten initial traction online but do not have the capability to build out the technology stack, AI expertise, and data capabilities necessary to massively scale in the US. All of these brands have gone through ZyG’s agentic Product Market Fit test and achieved a high ZyG Score, which predicts scale potential.
“Shopify and Amazon opened the door for anyone who wants to start selling online. But shifting from selling to scaling remains overwhelmingly complex. It forces founders to manage fragmented tools, siloed data, and the many teams or agencies needed to execute every aspect of scale,” said Omer Kaplan, CEO and Co-Founder of ZyG. “ZyG OS flips that model with an end-to-end solution that solves the entire problem, not pieces of it. With a complex agentic infrastructure, ZyG OS executes the endless elements needed to scale, freeing founders to focus on building great products.”
“The industry has spent years perfecting how we sell online, yet scaling remains fragmented and fragile,” said Sonali De Rycker, Partner at Accel. “By combining the ironSource founders’ commerce pedigree with deep AI expertise, the ZyG team has built the definitive Agentic Operating System that finally gives entrepreneurs the automated growth engine they need to scale.”
About ZyG
ZyG is an Operating System for eCom scale, turning great products into successful brands. ZyG’s platform is designed to help product inventors and DTC brands validate, scale, and finance their growth, powered by data-driven AI agents. For more information, visit www.zyg.com.
Перед новой компанией поставлена задача — управление проектом по расширению атомной станции V.C. Summer
КОЛУМБИЯ (штат Южная Каролина) и НЬЮ-ЙОРК, 5 мая 2026 г. — Brookfield, ведущая международная инвестиционная компания, и The Nuclear Company (TNC) — компания, специализирующаяся на разработке и реализации проектов в области атомной энергетики, сегодня объявили о заключении партнерского соглашения с целью создания новой компании для внедрения технологии ядерных реакторов Westinghouse. Целью партнерства является создание мирового лидера по реализации проектов в области атомной энергетики.
Обширные возможности Brookfield по управлению активами и развитию энергетической инфраструктуры в сочетании с опытом TNC по реализации проектов в сфере атомной энергетики послужат фундаментом для специализированной компании по разработке проектов. Компания будет предоставлять услуги по реализации проектов строительства атомных электростанций исключительно на базе технологии реакторов Westinghouse, включая модели AP1000 и AP300, а также полный цикл управления проектами, поддержку лицензирования и надзор за проектированием, закупками, строительством и пусконаладочными работами. Стороны рассчитывают в ближайшие месяцы перейти к подписанию окончательной документации при условии получения необходимых согласований и соблюдения стандартных процедур.
В рамках усилий по возможному завершению сооружения двух незаконченных энергоблоков AP1000 вблизи города Дженкинсвилла (Jenkinsville) в штате Южная Каролина компания Brookfield назначила нового управляющего проектом по расширению атомной станции в округе Фэрфилд (Fairfield) (Южная Каролина), официально известным как проект по сооружению энергоблоков №2 и №3 АЭС V.C. Summer (далее: «Проект»). Этот проект является одним из наиболее подготовленных к реализации в области атомной энергетики в США. Государственная энергетическая компания штата Южной Каролины Santee Cooper поддерживает участие новой компании в проекте.
Новая компания будет обеспечивать проведение контрольно-проверочных мероприятий и, в случае принятия Окончательного инвестиционного решения, курировать реализацию Проекта. Реализация проекта по-прежнему зависит от результатов дальнейшей оценки, получения разрешений надзорных органов и заключения окончательных соглашений.
«Это совместное предприятие отражает дисциплинированный подход компании Brookfield к крупномасштабным инфраструктурным инвестициям и ориентацию на партнерство с опытными операторами, — поделился Уайатт Хартли (Wyatt Hartley), управляющий партнер Brookfield. — Объединяя наши глобальные возможности по развитию инфраструктуры с опытом реализации проектов в области атомной энергетики, мы считаем, что эта платформа способна ускорить возрождение американской атомной энергетики, опираясь на динамику развития партнерства Westinghouse с правительством США».
«Наша команда сформировалась на площадке АЭС Vogtle и в ходе реализации нескольких самых сложных энергетических проектов в мире, — заявил Джо Клеча (Joe Klecha), руководитель ядерно-энергетического сектора The Nuclear Company. — Мы знаем, что необходимо для реализации проектов в области атомной энергетики. До сих пор не хватало модели, которая объединила бы людей, возможности и капитал, чтобы реализовывать такие проекты быстро и масштабно. Именно такую модель создает это партнерство».
О компании Brookfield
Brookfield — одна из ведущих глобальных инвестиционных компаний с активами на управлении на сумму более 1 трлн долларов, которая владеет и управляет реальными активами и предприятиями, предоставляющими жизненно важные услуги, составляющие основу мировой экономики. Компания, действуя от имени институциональных и частных инвесторов со всего мира, осуществляет инвестиции в инфраструктуру, возобновляемые источники энергии и энергетический переход, частный акционерный капитал, недвижимость и кредитование — ключевые секторы, обеспечивающие экономический рост и повышение производительности.
Имея более чем вековую историю и работая более чем в 30 странах, компания инвестирует долгосрочный, «терпеливый» капитал в строительство базовых активов и предприятий, которые станут основой для более взаимосвязанного, устойчивого и экологичного будущего, стремясь обеспечить долгосрочное благосостояние для своих клиентов и создавая при этом высокую доходность с учетом риска для своих акционеров. Brookfield Corporation (тикер: BN) и Brookfield Asset Management (тикер: BAM) — ведущий глобальный управляющий альтернативными активами со штаб-квартирой в Нью-Йорке — котируются на биржах NYSE и TSX.
Дополнительную информацию можно получить на веб-сайте www.brookfield.com.
О компании The Nuclear Company
The Nuclear Company является пионером модернизации строительства атомных объектов благодаря подходу «спроектировать один раз — строить многократно», опирающемуся на собственную платформу Nuclear Operating System (NOS) — систему на базе искусственного интеллекта, которая переводит сооружение реакторов всех типов в регулируемый, предсказуемый процесс, управляемый данными. Компания основана ветеранами ядерной энергетики и инфраструктурных энергопроектов, включая команду, которая ввела в эксплуатацию энергоблоки №3 и №4 АЭС Vogtle. TNC реализует проекты в области атомной энергетики и обслуживает действующие объекты, способствуя долгосрочной энергетической безопасности США.
Novo založená spoločnosť poslúži ako projektový manažér pre V.C. Summer
COLUMBIA, Južná Karolína a NEW YORK , 4. máj 2026 – Brookfield, popredná globálna investičná spoločnosť, a The Nuclear Company („TNC”), spoločnosť zameraná na vývoj a realizáciu jadrových projektov, dnes oznámili partnerstvo s cieľom založiť novú spoločnosť so špecializáciou na vývoj technológie jadrových reaktorov Westinghouse. Cieľom partnerstva je vytvoriť popredný globálny podnik v oblasti realizácie jadrových projektov.
Globálne schopnosti spoločnosti Brookfield v oblasti správy aktív a rozvoja energetickej infraštruktúry v kombinácii s odbornými znalosťami spoločnosti TNC v oblasti realizácie jadrových projektov poslúžia ako základ pre špecializovaný podnik zameraný na rozvoj projektov. Tento podnik bude ponúkať realizačné kapacity pre zavádzanie jadrových projektov založených výlučne na technológii reaktorov Westinghouse vrátane AP1000 a AP300, a ďalej komplexný projektový manažment, podporu udeľovania licencií a dohľad nad inžinierskymi, obstarávacími, stavebnými a uvádzaním do prevádzky. Zmluvné strany očakávajú, že v nasledujúcich mesiacoch dosiahnu pokrok smerom k finálnej dokumentácii, ktorá bude podliehať bežným schváleniam a podmienkam.
V rámci úsilia o potenciálny rozvoj dvoch čiastočne rozostavaných blokov AP1000 v blízkosti Jenkinsville v Južnej Karolíne si spoločnosť Brookfield vybrala tento nový podnik ako projektového manažéra pre jadrový projekt v okrese Fairfield v Južnej Karolíne, predtým známy ako 2. a 3. jadrový blok elektrárne V.C. Summer („projekt”). Tento projekt je jednou z najlepšie pripravených príležitostí v oblasti jadrového rozvoja v Amerike. Santee Cooper, spoločnosť vo vlastníctve štátu, ktorá poskytuje verejné služby v Južnej Karolíne, podporuje jej úlohu v projekte.
Novo založený podnik bude podporovať náležitú starostlivosť v rámci projektu a dohliadať na jeho realizáciu, ak sa posunie ku konečnému investičnému rozhodnutiu. Vývoj projektu je naďalej predmetom ďalšieho hodnotenia, schválenia regulačnými orgánmi a podpisu finálnych zmlúv.
„Tento spoločný podnik odráža disciplinovaný prístup spoločnosti Brookfield k rozsiahlym investíciám do infraštruktúry a zameranie na partnerstvo so skúsenými prevádzkovateľmi,” povedal Wyatt Hartley, riadiaci partner spoločnosti Brookfield. „Sme presvedčení, že kombináciou našich schopností v oblasti rozvoja globálnej infraštruktúry s odbornými znalosťami v oblasti realizácie jadrových projektov má táto platforma potenciál urýchliť oživenie americkej jadrovej energie a stavať na dynamike partnerstva spoločnosti Westinghouse s vládou USA.”
„Náš tím vznikal na stavenisku elektrárne Vogtle a pri realizácií jedných z najzložitejších energetických projektov na svete,” povedal Joe Klecha, hlavný jadrový riaditeľ spoločnosti The Nuclear Company. „Vieme, čo je na realizáciu jadrových projektov potrebné. Chýbal tu model, ktorý by spojil ľudí, schopnosti a kapitál, aby bolo možné to dosiahnuť rýchlo a vo veľkej mierke. Práve to prináša toto partnerstvo.”
O spoločnosti Brookfield
Brookfield je popredná globálna investičná spoločnosť, ktorá spravuje aktíva v hodnote viac ako 1 bilióna dolárov. Vlastní a prevádzkuje reálne aktíva a podniky poskytujúce základné služby, ktoré sú pilierom globálnej ekonomiky. Investujeme v mene inštitúcií aj jednotlivcov po celom svete v oblasti infraštruktúry, obnoviteľných zdrojov energie a transformácie, súkromného kapitálu, nehnuteľností a úverov – sektorov kľúčových pre podporu hospodárskeho rastu a produktivity.
S viac ako storočnou tradíciou a pôsobením vo viac ako 30 krajinách prostredníctvom dlhodobého, trpezlivého kapitálu budujeme základné aktíva a podniky, ktoré poháňajú prepojenejšiu, odolnejšiu a udržateľnejšiu budúcnosť. Snažíme sa budovať dlhodobé bohatstvo pre našich klientov a zároveň prinášať našim akcionárom silné výnosy upravené o riziko. Spoločnosti Brookfield Corporation (burzový symbol: BN) a Brookfield Asset Management (burzový symbol: BAM), popredný globálny správca alternatívnych aktív so sídlom v New Yorku, sú obe kótované na burzách NYSE a TSX.
Viac informácií nájdete na našej webovej stránke na adrese www.brookfield.com.
O spoločnosti The Nuclear Company
Nuclear Company je priekopníkom v modernizácii jadrovej výstavby prostredníctvom svojho prístupu „raz navrhnúť, viackrát postaviť”, ktorý je podložený vlastným jadrovým operačným systémom (NOS), platformou riadenou AI, ktorá transformuje výstavbu reaktorov pre všetky technológie na dátovo riadený a predvídateľný proces. Spoločnosť TNC, ktorú založili veteráni jadrovej energie a energetickej infraštruktúry vrátane tímu, ktorý uviedol do prevádzky 3. a 4. blok elektrárne Vogtle, nasadzuje jadrovú energiu a servisuje existujúce zariadenia s cieľom zaistiť dlhodobú energetickú bezpečnosť Ameriky.
Series B led by Peter Thiel funds manufacturing and first deployments of autonomous ocean-powered computing systems for a new class of AI infrastructure
PORTLAND, Ore., May 4, 2026 — Panthalassa, a renewable energy and ocean technology company, today announced $140 million in Series B financing led by Peter Thiel, with participation from new investors John Doerr, Marc Benioff’s TIME Ventures, Max Levchin’s SciFi Ventures, Susquehanna Sustainable Investments, Hanwha Group, Anthony Pratt, Fortescue Ventures, Future Positive, WTI, Nimble Partners, Super Micro Computer, Sozo Ventures, Dylan Field, Planetary VC, Leblon Capital, Resilience Reserve, Portland Seed Fund, and the Intrepid Oregon Fund. They are joined by returning investors Founders Fund, Gigascale Capital, Lowercarbon Capital, Unless, and WovenEarth. The funding will complete the company’s pilot manufacturing facility near Portland, Oregon, and accelerate deployment of its Ocean-3 series of nodes, which will perform AI inference computing at sea using power generated from ocean waves.
“There are three sources of energy on the planet with tens of terawatts of new capacity potential: solar, nuclear, and the open ocean,” said Garth Sheldon-Coulson, Co-Founder and CEO of Panthalassa. “We’ve built a technology platform that operates in the planet’s most energy-dense wave regions, far from shore, and turns that resource into reliable clean power. We’re now ready to build factories, deploy fleets, and provide a sustainable new source of energy for humanity.”
Panthalassa’s nodes are autonomous, floating energy systems that are mass-produced from plate steel in coastal factories. They operate in the distant ocean, where they generate clean electricity around the clock. Rather than transmitting energy back to terrestrial grids, Panthalassa uses it directly on board to power AI chips, sending inference tokens to land by satellite. The surrounding ocean provides free supercooling, eliminating one of the largest engineering challenges in land-based data centers and lengthening chip lifetimes.
Panthalassa has spent the past decade developing the core power generation, propulsion, autonomy, and at-sea computing technologies behind the platform. Its Ocean-1, Ocean-2, and Wavehopper prototypes in 2021 and 2024 proved these capabilities at sea. In 2026, the company plans to deploy its Ocean-3 pilot node series in the northern Pacific Ocean, demonstrating AI inference capabilities and refining its manufacturing process in preparation for commercial deployments in 2027.
As demand for new electricity and computing continues to surge, terrestrial data centers face mounting constraints: limited grid capacity, cooling water scarcity, supply chain bottlenecks, permitting delays, and impacts on local communities and infrastructure. Panthalassa’s platform expands energy and AI computing capacity without requiring new data centers or power plants on land—relieving strain on the grid, reducing ecological impacts, and lowering energy costs for families and businesses.
“The future demands more compute than we can imagine,” said Peter Thiel. “Extra-terrestrial solutions are no longer science fiction. Panthalassa has opened the ocean frontier.”
“Panthalassa’s autonomous wave power system is a game changer in addressing global energy needs and clean power generation,” said John Doerr. “It is a triple win: workers benefit, communities benefit, and we gain a strategic asset that strengthens American technological leadership.”
About Panthalassa
Panthalassa is a renewable energy and ocean technology company committed to ensuring a sustainable future for Earth by unlocking the vast energy potential of its oceans. Its self-propelled nodes capture wave energy and use it to generate clean electricity and run AI computing onboard, with data transmitted by low-Earth-orbit satellites. Panthalassa is a public benefit corporation headquartered in Portland, Oregon, and backed by leading investors. For more information, visit panthalassa.com.
Nowo utworzona spółka została wybrana na generalnego wykonawcę elektrowni jądrowej V.C. Summer.
COLUMBIA, Karolina Południowa i NOWY JORK, 4 maja 2026 r. — Brookfield Corporation, czołowa globalna firma inwestycyjna, oraz The Nuclear Company (TNC), spółka zajmująca się rozwijaniem i realizacją inwestycji jądrowych, ogłosiły dziś partnerstwo w celu utworzenia nowej firmy specjalizującej się w rozwijaniu technologii reaktorów jądrowych Westinghouse. Partnerstwo ma na celu stworzenie światowej klasy przedsiębiorstwa zajmującego się realizacją projektów jądrowych.
Fundamentem nowej spółki będą globalne kompetencje Brookfield w zakresie zarządzania aktywami i rozwoju infrastruktury energetycznej, w połączeniu z doświadczeniem TNC w realizacji projektów jądrowych. Nowy podmiot będzie oferował kompleksowe możliwości realizacyjne dla projektów opartych wyłącznie na technologii reaktorów Westinghouse, w tym AP1000 i AP300. Zakres działalności obejmie również kompleksowe zarządzanie projektami, wsparcie licencyjne oraz nadzór nad inżynierią, zaopatrzeniem, budową i uruchomieniem instalacji. Strony oczekują, że w nadchodzących miesiącach przejdą do finalizacji dokumentacji, z zastrzeżeniem standardowych zgód i warunków.
W ramach działań związanych z potencjalnym dokończeniem dwóch częściowo wybudowanych bloków AP1000 w pobliżu Jenkinsville w Karolinie Południowej, Brookfield wybrał nową spółkę na generalnego wykonawcę inwestycji w hrabstwie Fairfield, znanej formalnie jako V.C. Summer Nuclear Units 2 and 3 („Inwestycja”). Inwestycja ta jest jedną z najbardziej zaawansowanych pod względem gotowości realizacyjnej inwestycji jądrowych w Stanach Zjednoczonych. Santee Cooper, państwowe przedsiębiorstwo energetyczne Karoliny Południowej, wspiera rolę nowej spółki w tym przedsięwzięciu.
Nowa firma będzie wspierać proces due diligence oraz nadzorować realizację inwestycji w przypadku podjęcia ostatecznej decyzji inwestycyjnej (FID). Dalszy rozwój przedsięwzięcia pozostaje uzależniony od dodatkowych analiz, zgód regulacyjnych oraz zawarcia ostatecznych umów.
„Wspólny podmiot odzwierciedla zdyscyplinowane podejście Brookfield do inwestycji w infrastrukturę na dużą skalę oraz koncentrację na współpracy z doświadczonymi operatorami – powiedział Wyatt Hartley, partner zarządzający Brookfield Corporation. – Biorąc pod uwagę połączenie naszych globalnych kompetencji w zakresie rozwoju infrastruktury z doświadczeniem w realizacji projektów jądrowych, sądzimy, że ta platforma ma potencjał, aby przyspieszyć amerykański renesans energetyki jądrowej w oparciu o dynamikę partnerstwa Westinghouse z rządem Stanów Zjednoczonych”.
„Nasz zespół powstał na bazie doświadczeń zdobytych przy projekcie Vogtle oraz przy jednych z najbardziej złożonych projektów energetycznych na świecie – powiedział Joe Klecha, dyrektor ds. energetyki jądrowej w The Nuclear Company. – Wiemy, co jest potrzebne do realizacji inwestycji jądrowych. Brakowało tylko modelu, który połączy ludzi, kompetencje i kapitał, aby realizować je szybko i na dużą skalę. To właśnie tworzy to partnerstwo”.
Brookfield
Brookfield to czołowa globalna firma inwestycyjna zarządzająca aktywami o wartości przekraczającej 1 bilion dolarów. Spółka posiada i operuje aktywami realnymi oraz przedsiębiorstwami świadczącymi kluczowe usługi, które stanowią fundament globalnej gospodarki. Inwestuje w imieniu instytucji oraz inwestorów indywidualnych na całym świecie w infrastrukturę, odnawialne źródła energii i transformację energetyczną, private equity, nieruchomości oraz kredyty – sektory kluczowe dla wzrostu gospodarczego i produktywności.
Dzięki ponad stuletniej historii i obecności w ponad 30 krajach, firma lokuje długoterminowy, cierpliwy kapitał w budowę fundamentów gospodarki przyszłości, wspierając bardziej połączony, odporny i zrównoważony świat – dążąc jednocześnie do tworzenia długoterminowej wartości dla klientów i atrakcyjnych, skorygowanych o ryzyko zwrotów dla akcjonariuszy. Brookfield Corporation (symbol: BN) oraz Brookfield Asset Management (symbol: BAM), globalny zarządca aktywów alternatywnych z siedzibą w Nowym Jorku, są notowane na giełdach NYSE i TSX.
The Nuclear Company jest pionierem modernizacji budownictwa jądrowego poprzez podejście „zaprojektuj raz, buduj wielokrotnie”, wspierane przez opartą na sztucznej inteligencji autorską platformę Nuclear Operating System (NOS), która przekształca budowę reaktorów dla wszystkich technologii w przewidywalny proces oparty na danych. Firma została założona przez weteranów energetyki jądrowej i infrastruktury energetycznej, w tym zespół, który doprowadził do uruchomienia bloków Vogtle 3 i 4. TNC wdraża energetykę jądrową oraz świadczy usługi dla istniejących obiektów, aby zapewnić długoterminowe bezpieczeństwo energetyczne Stanów Zjednoczonych.
Investment reflects General Proximity’s strong scientific position and innovation in next-generation induced proximity medicines, and the interest in a potential future strategic collaboration from Daewoong Pharmaceutical.
SAN FRANCISCO, May 4, 2026 — FreeMind Investments (FMI), a venture capital fund launched in partnership between FreeMind Group and Daewoong Pharmaceutical Co., Ltd., today announced its investment in General Proximity, a San Francisco-based biotechnology company pioneering the next generation of induced proximity medicines.
General Proximity has built the first mechanism-agnostic proximity discovery engine centered on scanning the “effectome”—the set of effector proteins that can modulate disease causing proteins to control biology and enable the development of highly efficacious proximity therapeutics for targets previously beyond the reach of medicine. The company has raised over $20 million, secured five “Golden Ticket” awards from major pharma companies (AbbVie, Servier, Astellas, Ono, Bristol-Myers Squibb), received non-dilutive grants from ARPA-H and the NIH’s National Cancer Institute and most recently announced a strategic multi-target collaboration with Daiichi Sankyo applying its proprietary OmniTAC platform to several oncology programs. The company is advancing its own programs across oncology, cardiometabolic disease, neurodegeneration, and longevity.
FreeMind Group, founded in 1999, is the leading non-dilutive funding consultancy for life science organizations, having secured over $2 billion for its clients to date and garnering over $100 million annually. FMI leverages this unique vantage point—using the non-dilutive funding review process as a differentiated due diligence tool to identify high-conviction investment candidates early—while also providing investees with pharma deal-making access, including co-development opportunities and entry into the Asian market.
Established in 1945, Daewoong Pharmaceutical Co., Ltd. is a leading South Korean pharmaceutical company developing, manufacturing, and commercializing first-in-class and best-in-class pharmaceuticals across global markets, with strategic partnerships in more than 100 countries. This investment reflects Daewoong Pharmaceutical’s strategic interest in General Proximity’s platform and its intent to explore a future strategic collaboration.
“FMI was built to translate deep non-dilutive funding intelligence into investment conviction,” said Ram May-Ron, Founder and Managing Partner at FreeMind Investments. “General Proximity stands out for the quality of its science, the strength of its team, and its potential to unlock new therapeutic options for targets long considered out of reach.”
“We see significant strategic potential in General Proximity’s induced proximity approach,” said Seongsoo Park, CEO, Daewoong Pharmaceutical Co., Ltd. “We look forward to building a future strategic collaboration with the General Proximity team.”
“We are excited to welcome FreeMind Investments and Daewoong Pharmaceutical as investors,” said Armand Cognetta, Founder & Chief Executive Officer of General Proximity. “Their investment conviction and deep expertise in drug discovery validates our scientific approach and the high-impact pipeline we are building.”
ABOUT FREEMIND INVESTMENTS (FMI)
FreeMind Investments (FMI) is a venture capital fund launched in partnership between FreeMind Group and Daewoong Pharmaceutical Co., Ltd., making direct equity investments while leveraging the non-dilutive funding review process to identify promising life science investment opportunities and bridge the biotech startup “valley of death.”
ABOUT FREEMIND GROUP
Founded in 1999, FreeMind Group is the leading non-dilutive funding consultancy for life science organizations, having helped clients secure over $2 billion in funding to date, garnering over $100 million annually across NIH, DoD, BARDA, NSF, FDA, and private foundations.
ABOUT DAEWOONG PHARMACEUTICAL CO., LTD.
Established in 1945, Daewoong Pharmaceutical Co., Ltd. is a leading South Korean pharmaceutical company that develops, manufactures, and commercializes pharmaceuticals globally, with in-house R&D capabilities, international operations across Asia and the United States, and strategic partnerships in more than 100 countries worldwide.
ABOUT GENERAL PROXIMITY
General Proximity is a biotechnology company advancing next-generation induced proximity medicines. Its proprietary OmniTAC™ platform enables unbiased identification of effector proteins capable of modulating disease-relevant targets, unlocking new opportunities across oncology and other therapeutic areas. The company is advancing multiple preclinical programs generated by the OmniTAC™ platform.
Includes N47-Led Series A Round Following Rapid Customer Growth to Fund Expansion Into Skilled Nursing and Hospice Care
LEHI, Utah, May 4, 2026 — Enzo Health, the AI-driven platform for home health and post-acute care, today announced its $20M Series A funding round led by N47, bringing the company’s total funding to $26M. The funding positions Enzo to meet surging demand for in-home care, which is accelerating as more than 10,000 Americans turn 65 every day. Existing investors Gradient, Tandem Ventures, and Rigby Watts also participated.
Enzo’s AI-driven platform automates and connects home health and post-acute care providers’ front office, clinical operations, and back office functions in one system, handling the entire workflow from referral to reimbursement while minimizing regulatory risk. Where legacy home health software left agencies cobbling together disconnected point solutions and incurring unnecessary costs and time spend, Enzo Health’s solution bolsters care providers’ margins, returns precious hours to nurses and clinicians and allows patients to receive care in the settings in which they are most comfortable.
Launched in 2024, Enzo Health has grown revenue by more than 40X in twelve months and is now used by organizations that support over 500,000 patients annually.
Zach Newman, co-founder and CEO of Enzo Health, said, “Home health is one of the fastest-growing segments in healthcare due to the rapidly expanding 65+ demographic. But the agencies delivering that care are being squeezed from every direction. Their compliance and operational requirements keep growing, while the solutions they’re using were never built to handle these demands. The result is burned-out clinicians, unsustainable turnover, and patients who can’t get the care they need. Enzo fixes that.”
Seven out of 10 Americans will require long-term care at some point in their lifetime, according to the U.S. Department of Health and Human Services. With 73 million Baby Boomers increasingly gravitating toward home health, jobs in the sector are expected to grow by roughly 17% from 2024 to 2034, according to the Bureau of Labor Statistics.
Unfortunately, Medicare reimbursement cuts, tougher regulations, workforce shortages, and shrinking margins have made it difficult for home health agencies to meet that demand. According to the Home Care Association of America, home health clinician turnover hovers near 80% within the first 100 days, as nurses and clinicians are frequently forced to work long hours to keep up with documentation for billing, regulatory compliance and quality assurance at the same time as they care for patients.
Enzo’s AI-driven platform addresses these challenges by streamlining home health providers’ core workflows, connecting and automating the following in one system:
Enzo Intake analyzes referrals instantly, converts faxes, emails, and PDFs into structured data, and checks eligibility in seconds before staff review is needed
Enzo Scribe delivers OASIS validation and AI-assisted documentation in real-time during a visit, so clinicians finish charting before they leave the patient’s home
Enzo QA continuously reviews charts for clinical and regulatory accuracy, catching issues before they affect reimbursement or compliance
Enzo Health plans to use part of the funds from its Series A to expand into the skilled nursing and hospice sectors by extending its AI-driven platform to address the unique clinical, operational, and regulatory workflows of each setting, enabling providers to operate more efficiently while maintaining high-quality care.
Vivian Cheng, Partner at N47 said, “Enzo is redefining how home health organizations operate, removing the administrative burden that has long defined the industry and enabling clinicians and agencies to serve more patients. By building an AI-native platform from the ground up, Enzo is enabling a level of automation and efficiency that legacy systems simply can’t match. We’re proud to back Zach and the Enzo team as they scale their vision for post-acute care. The impact for providers and patients alike will be enormous.”
Andrew Brackin, Partner at Gradient, said, “As America ages, home health is becoming one of the most important care settings. Yet the agencies delivering that care are still too often held back by documentation-heavy workflows and fragmented legacy software. The category does not need another disconnected AI point solution. It needs a platform. We led Enzo’s seed round because Zach, Dan, and the team were moving exceptionally fast toward a clear and ambitious vision: building the AI-native platform for home health.”
About Enzo Health Enzo Health is an AI-driven platform built specifically for home health. Connecting front office, clinical, and back office operations in one system, Enzo automates each stage of the patient journey from referral to revenue, helping agencies take on more patients, protect their reimbursement, and give their clinicians time to focus on care.
Media Contact Chris Clemens Nexios Communications Strategies [email protected]
